Momentus Inc. Raises $5 Million in At‑The‑Market Private Placement to Fund Upcoming Vigoride‑7 Launch

MNTS
January 06, 2026

Momentus Inc. (NASDAQ: MNTS) announced a $5 million at‑the‑market private placement on January 5, 2026. The transaction sold 925,926 shares of common stock and issued warrants to purchase an additional 925,926 shares at an exercise price of $5.40 per share. The warrants expire five years from the initial exercise date and are subject to shareholder approval. The deal, completed with a single institutional investor, is expected to close on or about January 6, 2026, providing the company with net proceeds of approximately $5 million for working capital and general corporate purposes.

The capital raise is intended to support Momentus’s operating needs and the upcoming Vigoride‑7 launch, scheduled for no earlier than March 2026 on SpaceX’s Transporter‑16 mission. Vigoride‑7 will carry payloads for the U.S. Defense Department, NASA, and commercial customers, representing a significant revenue opportunity for the company. The funding will help cover launch costs, manufacturing of the 3‑D‑printed fuel tank, and other mission‑critical expenses.

Momentus has faced financial challenges in recent years, reporting negative earnings per share and net losses, and issuing a reverse stock split and going‑concern warnings in 2025. The $5 million infusion is therefore a critical step to shore up liquidity and maintain operational momentum while the company continues to invest in its additive‑manufacturing capabilities and expand its launch portfolio.

The private placement agreement also includes amendments to existing warrants issued in October and December 2025, reducing the exercise price from $13.74 to $5.40. This change, pending shareholder approval, could lead to significant dilution if the warrants are exercised, underscoring the importance of monitoring shareholder votes and future capital structure developments.

On the day of the announcement, Momentus’s stock surged 58% in intraday trading, driven primarily by the news that the company had developed an additive‑manufactured fuel tank for Vigoride‑7. CEO John Rood highlighted the achievement as a “major milestone” that “opens new possibilities for spacecraft design and production.” The private‑placement announcement added to the positive sentiment, but the additive‑manufacturing breakthrough was the main catalyst for investor enthusiasm.

The private placement, combined with the company’s ongoing investment in advanced manufacturing and its upcoming launch schedule, positions Momentus to capitalize on growing demand for in‑space transportation services. Investors will watch for the company’s ability to convert the capital into operational milestones and for shareholder approval of the warrant amendments, which could affect future dilution and valuation.

The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.